Dyne Therapeutics (DYN) Retained Earnings (2019 - 2026)
Dyne Therapeutics' (DYN) quarterly Retained Earnings came in at $2.4 billion in Q1 2026, up 988353.11% year-on-year from N/an in Q1 2025, and up 501409.89% on a QoQ basis from $475000.0 in Q4 2025.
Dyne Therapeutics (DYN) Retained Earnings (2019 - 2026) Analysis & Trends
Dyne Therapeutics (DYN) has 8 years of Retained Earnings data on file, last reported at $2.4 billion in Q1 2026.
- On a quarterly basis, Retained Earnings rose 988353.11% year-over-year to $2.4 billion in Q1 2026; TTM through Mar 2026 was $2.4 billion, a 988353.11% increase from a year earlier, with the FY2025 full-year figure at $475000.0, down 99.97% from the prior year.
- Retained Earnings for Q1 2026 stood at $2.4 billion, up from $475000.0 in the prior quarter.
- Over the last five years, Retained Earnings for DYN reached as high as $2.4 billion in Q1 2026 and fell as low as -$698.2 million in Q1 2024.
- Historically, Retained Earnings has averaged $396.1 million across 5 years, with a median of $475000.0 in 2025.
- On a YoY basis, Retained Earnings climbed as much as 1789708.82% in 2022 and fell as far as 147324.91% in 2022.
- Year by year, Retained Earnings stood at -$396.6 million in 2022, then sank by 59.49% to -$632.5 million in 2023, then surged by 349.76% to $1.6 billion in 2024, then sank by 99.97% to $475000.0 in 2025, then soared by 501409.89% to $2.4 billion in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were $2.4 billion in Q1 2026, $475000.0 in Q4 2025, and $2.0 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Dyne Therapeutics | 3.94 Bn | 3.94 Bn | - | 2.38 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.38 Bn |
| Dec 31, 2025 | 475,000.00 |
| Sep 30, 2025 | 1.98 Bn |
| Jun 30, 2025 | 252,000.00 |
| Mar 31, 2025 | 241,000.00 |
| Dec 31, 2024 | 1.58 Bn |
| Sep 30, 2024 | 478,000.00 |
| Jun 30, 2024 | 1.54 Bn |
| Mar 31, 2024 | -698.16 Mn |
| Dec 31, 2023 | -632.51 Mn |
| Sep 30, 2023 | 717.92 Mn |
| Jun 30, 2023 | -505.66 Mn |
| Mar 31, 2023 | -440.76 Mn |
| Dec 31, 2022 | -396.57 Mn |
| Sep 30, 2022 | 608.47 Mn |
| Jun 30, 2022 | 604.57 Mn |
| Mar 31, 2022 | -930,000.00 |
| Dec 31, 2021 | -269,000.00 |
| Sep 30, 2021 | -34,000.00 |
| Jun 30, 2021 | -41,000.00 |